Related Experiment Video
Updated: Jul 18, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
General dentistry during continuous anticoagulation therapy.
Anticoagulated patients can safely undergo dental procedures without altering their medication. Monitoring prothrombin time ensured minimal risk of postoperative bleeding complications, with all hemorrhages easily managed.
Area of Science:
- Dentistry
- Hematology
Background:
- Dental procedures in patients on anticoagulation therapy require careful management to prevent hemorrhagic complications.
- Maintaining therapeutic anticoagulation levels is crucial for preventing thromboembolic events but poses bleeding risks during surgery.
Purpose of the Study:
- To assess the incidence and management of postoperative hemorrhagic complications in anticoagulated patients undergoing general dental procedures.
- To determine the safety of performing dental procedures without altering anticoagulant regimens.
Main Methods:
- Seventy-four dental visits involving eighty-five procedures were monitored in anticoagulated patients.
- Patients' prothrombin time was assessed immediately before dental procedures to ensure levels were below the maximum therapeutic range.
- The anticoagulant regimen was not modified for any of the procedures.
Main Results:
- No significant postoperative hemorrhagic complications were observed.
- All instances of minor hemorrhage were effectively controlled using local measures.
- The absence of altered anticoagulant regimens did not lead to unmanageable bleeding.
Conclusions:
- General dental procedures can be safely performed in anticoagulated patients without altering their medication.
- Pre-procedural prothrombin time monitoring is an effective strategy to minimize bleeding risks.
- Local hemostatic measures are sufficient for managing minor hemorrhages in this patient group.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Tonsillitis II: Management
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management

